Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/34051879/ below:

Impact of COVID-19 on cancer care in India: a cohort study

Multicenter Study

Affiliations

• ¹ Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
• ² Birla Institute of Medical Research Hospital, Gwalior, India.
• ³ G Kuppuswamy Naidu Memorial Hospital, Coimbatore, India.
• ⁴ Healthcare Global Cancer Centre, Vadodara, India.
• ⁵ Healthcare Global Cancer Centre, Bengaluru, India.
• ⁶ Chittaranjan National Cancer Institute, Kolkata, India.
• ⁷ Aster Malabar Institute of Medical Sciences, Calicut, India.
• ⁸ Max Super Speciality Hospital, Saket, New Delhi, India.
• ⁹ Padhar Hospital, Betul, India.
• ¹⁰ Paras Cancer Centre, Patna, India.
• ¹¹ Bhubaneswar Borooah Cancer Institute, Guwahati, India.
• ¹² Max Super Speciality Hospital, Shalimar Bagh, New Delhi, India.
• ¹³ North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, India.
• ¹⁴ Ruby Hall Clinic, Pune, India.
• ¹⁵ Sri Venkateswara Institute of Medical Sciences, Tirupati, India.
• ¹⁶ All India Institute of Medical Sciences, Rishikesh, India.
• ¹⁷ Kailash Cancer Hospital and Research Centre, Goraj, India.
• ¹⁸ Prince Aly Khan Hospital, Mumbai, India.
• ¹⁹ Dr Vikhe Patil Radiation and Cancer Centre, Ahmednagar, India.
• ²⁰ Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India.
• ²¹ Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam, India.
• ²² Sri Ram Cancer Center, Mahatma Gandhi Medical College Hospital, Jaipur, India.
• ²³ Cytecare Cancer Hospitals, Bengaluru, India.
• ²⁴ Thangam Hospital, Namakkal, India.
• ²⁵ Regional Cancer Centre, Thiruvananthapuram, India.
• ²⁶ Gujarat Cancer and Research Institute, Ahmedabad, India.
• ²⁷ Bhagwan Mahaveer Cancer Hospital and Research Centre, Jaipur, India.
• ²⁸ Mizoram State Cancer Institute, Aizawl, India.
• ²⁹ Christian Medical College, Vellore, India.
• ³⁰ Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Varanasi, India.
• ³¹ Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, India.
• ³² Cancer Institute (WIA), Chennai, India.
• ³³ Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India.
• ³⁴ Rashtrasant Tukdoji Tertiary Care Cancer Centre, Nagpur, India.
• ³⁵ Balco Medical Centre, Raipur, India.
• ³⁶ Sawai Man Singh Hospital, Jaipur, India.
• ³⁷ Cachar Cancer Hospital and Research Centre, Silchar, India.
• ³⁸ Kovai Medical Center and Hospital, Coimbatore, India.
• ³⁹ Healthcare Global Cancer Centre, Ahmedabad, India.
• ⁴⁰ Tata Medical Center, Kolkata, India.
• ⁴¹ Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. Electronic address: prameshcs@tmc.gov.in.

• PMID: 34051879
• PMCID: PMC8159191
• DOI: 10.1016/S1470-2045(21)00240-0

Item in Clipboard

Multicenter Study

Priya Ranganathan et al. Lancet Oncol. 2021 Jul.

• ¹ Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
• ² Birla Institute of Medical Research Hospital, Gwalior, India.
• ³ G Kuppuswamy Naidu Memorial Hospital, Coimbatore, India.
• ⁴ Healthcare Global Cancer Centre, Vadodara, India.
• ⁵ Healthcare Global Cancer Centre, Bengaluru, India.
• ⁶ Chittaranjan National Cancer Institute, Kolkata, India.
• ⁷ Aster Malabar Institute of Medical Sciences, Calicut, India.
• ⁸ Max Super Speciality Hospital, Saket, New Delhi, India.
• ⁹ Padhar Hospital, Betul, India.
• ¹⁰ Paras Cancer Centre, Patna, India.
• ¹¹ Bhubaneswar Borooah Cancer Institute, Guwahati, India.
• ¹² Max Super Speciality Hospital, Shalimar Bagh, New Delhi, India.
• ¹³ North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, India.
• ¹⁴ Ruby Hall Clinic, Pune, India.
• ¹⁵ Sri Venkateswara Institute of Medical Sciences, Tirupati, India.
• ¹⁶ All India Institute of Medical Sciences, Rishikesh, India.
• ¹⁷ Kailash Cancer Hospital and Research Centre, Goraj, India.
• ¹⁸ Prince Aly Khan Hospital, Mumbai, India.
• ¹⁹ Dr Vikhe Patil Radiation and Cancer Centre, Ahmednagar, India.
• ²⁰ Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India.
• ²¹ Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam, India.
• ²² Sri Ram Cancer Center, Mahatma Gandhi Medical College Hospital, Jaipur, India.
• ²³ Cytecare Cancer Hospitals, Bengaluru, India.
• ²⁴ Thangam Hospital, Namakkal, India.
• ²⁵ Regional Cancer Centre, Thiruvananthapuram, India.
• ²⁶ Gujarat Cancer and Research Institute, Ahmedabad, India.
• ²⁷ Bhagwan Mahaveer Cancer Hospital and Research Centre, Jaipur, India.
• ²⁸ Mizoram State Cancer Institute, Aizawl, India.
• ²⁹ Christian Medical College, Vellore, India.
• ³⁰ Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Varanasi, India.
• ³¹ Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, India.
• ³² Cancer Institute (WIA), Chennai, India.
• ³³ Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India.
• ³⁴ Rashtrasant Tukdoji Tertiary Care Cancer Centre, Nagpur, India.
• ³⁵ Balco Medical Centre, Raipur, India.
• ³⁶ Sawai Man Singh Hospital, Jaipur, India.
• ³⁷ Cachar Cancer Hospital and Research Centre, Silchar, India.
• ³⁸ Kovai Medical Center and Hospital, Coimbatore, India.
• ³⁹ Healthcare Global Cancer Centre, Ahmedabad, India.
• ⁴⁰ Tata Medical Center, Kolkata, India.
• ⁴¹ Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. Electronic address: prameshcs@tmc.gov.in.

• PMID: 34051879
• PMCID: PMC8159191
• DOI: 10.1016/S1470-2045(21)00240-0

Item in Clipboard

Background: The COVID-19 pandemic has disrupted health-care systems, leading to concerns about its subsequent impact on non-COVID disease conditions. The diagnosis and management of cancer is time sensitive and is likely to be substantially affected by these disruptions. We aimed to assess the impact of the COVID-19 pandemic on cancer care in India.

Methods: We did an ambidirectional cohort study at 41 cancer centres across India that were members of the National Cancer Grid of India to compare provision of oncology services between March 1 and May 31, 2020, with the same time period in 2019. We collected data on new patient registrations, number of patients visiting outpatient clinics, hospital admissions, day care admissions for chemotherapy, minor and major surgeries, patients accessing radiotherapy, diagnostic tests done (pathology reports, CT scans, MRI scans), and palliative care referrals. We also obtained estimates from participating centres on cancer screening, research, and educational activities (teaching of postgraduate students and trainees). We calculated proportional reductions in the provision of oncology services in 2020, compared with 2019.

Findings: Between March 1 and May 31, 2020, the number of new patients registered decreased from 112 270 to 51 760 (54% reduction), patients who had follow-up visits decreased from 634 745 to 340 984 (46% reduction), hospital admissions decreased from 88 801 to 56 885 (36% reduction), outpatient chemotherapy decreased from 173634 to 109 107 (37% reduction), the number of major surgeries decreased from 17 120 to 8677 (49% reduction), minor surgeries from 18 004 to 8630 (52% reduction), patients accessing radiotherapy from 51 142 to 39 365 (23% reduction), pathological diagnostic tests from 398 373 to 246 616 (38% reduction), number of radiological diagnostic tests from 93 449 to 53 560 (43% reduction), and palliative care referrals from 19 474 to 13 890 (29% reduction). These reductions were even more marked between April and May, 2020. Cancer screening was stopped completely or was functioning at less than 25% of usual capacity at more than 70% of centres during these months. Reductions in the provision of oncology services were higher for centres in tier 1 cities (larger cities) than tier 2 and 3 cities (smaller cities).

Interpretation: The COVID-19 pandemic has had considerable impact on the delivery of oncology services in India. The long-term impact of cessation of cancer screening and delayed hospital visits on cancer stage migration and outcomes are likely to be substantial.

Funding: None.

Translation: For the Hindi translation of the abstract see Supplementary Materials section.

Copyright © 2021 Elsevier Ltd. All rights reserved.

PubMed Disclaimer

Declaration of interests AC reports personal fees from AstraZeneca, Novartis, Merck, Eli Lilly, Pfizer, Dr Reddy's, and Intas, outside the submitted work. All other authors declare no competing interests.

• Consequences of the COVID-19 pandemic on lung cancer care and patient health in a German lung cancer center: results from a cross-sectional questionnaire.

  Walter J, Sellmer L, Kahnert K, Kiefl R, Syunyaeva Z, Kauffmann-Guerrero D, Manapov F, Schneider C, Behr J, Tufman A. Walter J, et al. Respir Res. 2022 Jan 29;23(1):18. doi: 10.1186/s12931-022-01931-z. Respir Res. 2022. PMID: 35093079 Free PMC article.

• Impact of COVID-19 on cancer diagnosis and management in Slovenia - preliminary results.

  Zadnik V, Mihor A, Tomsic S, Zagar T, Bric N, Lokar K, Oblak I. Zadnik V, et al. Radiol Oncol. 2020 Jul 29;54(3):329-334. doi: 10.2478/raon-2020-0048. Radiol Oncol. 2020. PMID: 32726291 Free PMC article.

• Decrease of oncological patients' hospital visits during Covid-19 pandemic; the experience of a tertiary Romanian centre.

  Crisan C, Cainap C, Deac A, Havasi A, Balacescu O, Balacescu L, Bochis O, Vlad C, Cainap S. Crisan C, et al. J BUON. 2021 May-Jun;26(3):1121-1126. J BUON. 2021. PMID: 34268980

• Advances in surgery in 2020: The impact of the COVID-19 pandemic on cancer surgeries and cancer care - a brief overview.

  Krishnamurthy A. Krishnamurthy A. Indian J Cancer. 2021 Jan-Mar;58(1):38-40. doi: 10.4103/ijc.IJC_1271_20. Indian J Cancer. 2021. PMID: 33762484 Review. No abstract available.

• Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.

  Marshall M, Crowther R, Almaraz-Serrano A, Creed F, Sledge W, Kluiter H, Roberts C, Hill E, Wiersma D, Bond GR, Huxley P, Tyrer P. Marshall M, et al. Health Technol Assess. 2001;5(21):1-75. doi: 10.3310/hta5210. Health Technol Assess. 2001. PMID: 11532238 Review.

• The SARS-CoV2 pandemic and routine immunisation.

  Kang G. Kang G. Lancet Glob Health. 2022 Feb;10(2):e155-e156. doi: 10.1016/S2214-109X(21)00543-X. Lancet Glob Health. 2022. PMID: 35063102 Free PMC article. No abstract available.

• Identifying predictors of COVID-related delays in cancer-specific medical care.

  Greteman BB, Del Vecchio NJ, Garcia-Auguste CJ, Kahl AR, Gryzlak BM, Chrischilles EA, Charlton ME, Nash SH. Greteman BB, et al. Cancer Med. 2024 Apr;13(8):e7183. doi: 10.1002/cam4.7183. Cancer Med. 2024. PMID: 38629238 Free PMC article.

• Characteristics & outcomes of cancer patients with COVID-19: A multicentre retrospective study from India.

  Kumar A, Baghmar S, Mehta P, Tiwari P, Kumar L, Bakhshi S, Agarwal A, Gupta I, Trikha A, Bhatnagar S, Gogia A, Malik PS, Sahoo RK, Rastogi S, Pramanik R, Batra A, Pushpam D, Sharma CK, Sharma V, Kataria B, Goyal K, Samaga S, Bothra SJ, Sharma A. Kumar A, et al. Indian J Med Res. 2022 May-Jun;155(5&6):546-553. doi: 10.4103/ijmr.ijmr_1703_21. Indian J Med Res. 2022. PMID: 36348601 Free PMC article.

• Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic.

  Walker MJ, Wang J, Mazuryk J, Skinner SM, Meggetto O, Ashu E, Habbous S, Nazeri Rad N, Espino-Hernández G, Wood R, Chaudhry M, Vahid S, Gao J, Gallo-Hershberg D, Gutierrez E, Zanchetta C, Langer D, Zwicker V, Rey M, Tammemägi MC, Tinmouth J, Kupets R, Chiarelli AM, Singh S, Warde P, Forbes L, Dobranowski J, Irish J, Rabeneck L; Cancer Care Ontario COVID-19 Impact Working Group. Walker MJ, et al. JAMA Netw Open. 2022 Apr 1;5(4):e228855. doi: 10.1001/jamanetworkopen.2022.8855. JAMA Netw Open. 2022. PMID: 35467731 Free PMC article.

• Delayed visit and treatment of lung cancer during the coronavirus disease 2019 pandemic in Japan: a retrospective study.

  Terashima T, Tsutsumi A, Iwami E, Kuroda A, Nakajima T, Eguchi K. Terashima T, et al. J Int Med Res. 2022 May;50(5):3000605221097375. doi: 10.1177/03000605221097375. J Int Med Res. 2022. PMID: 35579175 Free PMC article.

1. 1. Watkins J, Wulaningsih W. Three further ways that the COVID-19 pandemic will affect health outcomes. Int J Public Health. 2020;65:519–520. - PMC - PubMed
2. 1. Rosenbaum L. The untold toll—the pandemic's effects on patients without Covid-19. New Engl J Med 202; 382: 2368–71. - PubMed
3. 1. Jereczek-Fossa BA, Pepa M, Marvaso G, et al. COVID-19 outbreak and cancer radiotherapy disruption in Italy: survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Radiother Oncol. 2020;149:89–93. - PMC - PubMed
4. 1. Vasquez L, Sampor C, Villanueva G, et al. Early impact of the COVID-19 pandemic on paediatric cancer care in Latin America. Lancet Oncol. 2020;21:753–755. - PMC - PubMed
5. 1. Martinez D, Sarria GJ, Wakefield D, et al. COVID's impact on radiation oncology: a Latin American survey study. Int J Radiat Oncol Biol Phys. 2020;108:374–378. - PMC - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3